You are here

CDMO

CDMO makes an AI and drug discovery play in latest, small-time acquisition

CDMO makes an AI and drug discovery play in latest, small-time acquisition

Endpoints

artificial intelligence

RubrYc Therapeutics

Flag link:

Sanofi's CDMO spinoff set for next month as new group targets 2022 revenues of €1B

Sanofi's CDMO spinoff set for next month as new group targets 2022 revenues of €1B

Fierce Pharma

Flag link:

Fujifilm Diosynth in $300m expansion of largest single-use facility in North America

Fujifilm Diosynth in $300m expansion of largest single-use facility in North America

Biopharma Reporter

Fujifilm Diosynth Biotechnologies

Flag link:

Moderna bags another US CDMO to help with fill-finish work for its vaccine amid booster push

Moderna bags another US CDMO to help with fill-finish work for its vaccine amid booster push

Endpoints

Moderna Therapeutics

ThermoFisher Scientific

drug manufacturing

Flag link:

Charles River lays out $293M to snap up viral vector specialist Vigene, its 2nd M&A deal this year

Charles River lays out $293M to snap up viral vector specialist Vigene, its 2nd M&A deal this year

Fierce Pharma

Charles River Laboratories

Flag link:

Chime Bio, flush with $190M, blueprints major biomanufacturing boost in China

Chime Bio, flush with $190M, blueprints major biomanufacturing boost in China

Fierce Pharma

drug manufacturing

Flag link:

Bristol Myers offloading Swiss tablet and capsule plant to Chinese CDMO WuXi STA

Bristol Myers offloading Swiss tablet and capsule plant to Chinese CDMO WuXi STA

Fierce Pharma

Bristol-Myers Squibb

ISTA Pharmaceuticals

Flag link:

Looking for an edge in vaccines, Thermo Fisher plots major expansions across global manufacturing sites in its portfolio

Looking for an edge in vaccines, Thermo Fisher plots major expansions across global manufacturing sites in its portfolio

Endpoints

drug manufacturing

Flag link:

Baxter's CDMO arm will add 100 new positions in $50M fill-finish expansion of Indiana plant

Baxter's CDMO arm will add 100 new positions in $50M fill-finish expansion of Indiana plant

Fierce Pharma

Baxter International

drug manufacturing

Flag link:

Catalent continues big push into cell and gene therapies with Belgian facility buyout

Catalent continues big push into cell and gene therapies with Belgian facility buyout

Fierce Pharma

Flag link:

Fledgling Indiana CDMO Incog plots first injectables manufacturing facility

Fledgling Indiana CDMO Incog plots first injectables manufacturing facility

Fierce Pharma

Incog Biopharma Services

Flag link:

CPhI: Private equity involvement in emerging biopharma sector growing

CPhI: Private equity involvement in emerging biopharma sector growing

Biopharma Reporter

Flag link:

Fujifilm expands its gene therapy drug CDMO business

Fujifilm expands its gene therapy drug CDMO business

Biopharma Reporter

Flag link:

Arranta Bio set to boost manufacturing for growing pipeline of microbiome drugs

Arranta Bio set to boost manufacturing for growing pipeline of microbiome drugs

BioPharma Dive

drug manufacturing

Flag link:

AstraZeneca signs on Albany Molecular to help boost COVID-19 shot production

AstraZeneca signs on Albany Molecular to help boost COVID-19 shot production

Fierce Pharma

Albany Molecular Research

Flag link:

AstraZeneca ropes in Catalent gene therapy site to produce viral vectors for COVID-19 vaccine

AstraZeneca ropes in Catalent gene therapy site to produce viral vectors for COVID-19 vaccine

Fierce Pharma

Flag link:

FDA rails at California CDMO for failing to secure data used to determine strength of its drugs

FDA rails at California CDMO for failing to secure data used to determine strength of its drugs

Fierce Pharma

Stason Pharmaceuticals

drug manufacturing

Flag link:

Moderna aims for light-speed COVID-19 shot rollout with Catalent fill-finish deal

Moderna aims for light-speed COVID-19 shot rollout with Catalent fill-finish deal

Fierce Pharma

Moderna Therapeutics

Flag link:

Fujifilm doubles down on ex-Biogen facility with $928M infusion as biotech boom fuels CDMO growth

Fujifilm doubles down on ex-Biogen facility with $928M infusion as biotech boom fuels CDMO growth

Endpoints

drug manufacturing

Flag link:

Empty AstraZeneca plant sized up by CDMO which may or may not be AGC Biologics

Empty AstraZeneca plant sized up by CDMO which may or may not be AGC Biologics

Fierce Pharma

drug manufacturing

Flag link:

Pages